基于MOF的纳米平台可实现对结肠癌进行协同作用的低氧激活化疗和化学动力疗法
Hongfu Liu1, Zhendong Long1, Feiyang Xu1
1School of Biological and Food Engineering, Anhui Polytechnic University, Wuhu, Anhui 241000, People's Republic of China.
ACS applied materials & interfaces
|September 27, 2025
概括
这项研究开发了一种针对结肠癌的新型纳米疗法平台,它结合了化疗和化学动力疗法. 该平台通过向瘤微环境和激活前期药物来提高治疗效率,从而改善单一治疗的结果.
科学领域:
- 在瘤学瘤学.
- 纳米医学是一种纳米医学.
- 生物化学 生物化学
背景情况:
- 结肠癌带来了重大的治疗挑战,因为目前单一治疗的疗效和副作用有限.
- 瘤微环境 (TME) 的因素,如缺氧和低氧化物 (H2O2) 限制治疗的有效性.
- 需要新的策略来克服TME的局限性,并改善结肠癌治疗结果.
研究的目的:
- 开发一种新的纳米疗法平台 (TL@Cu/Z-PF) 用于协同治疗结肠癌.
- 为了同时提供β-lapachone (Lap) 和tirapazamine (TPZ),使用适应pH值的,合铜的化石化imidazolate框架.
- 通过聚乙烯糖醇 - 叶酸功能化来增强向的输送和治疗疗效.
主要方法:
- 构建了一个pH响应的,可生物降解的纳米平台 (TL@Cu/Z-PF) 共同提供拉普和TPZ.
- 用聚乙烯糖醇 - 叶酸功能化纳米平台,用于有针对性的交付.
- 研究了TME中低氧激活化疗和铜介导化学动力学疗法 (CDT) 的协同效应.
主要成果:
- TL@Cu/Z-PF在酸性TME中表现出pH响应性降解,释放Cu2+和治疗剂.
- 2+离子耗尽了谷氨,产生了+,这促进了类似芬顿的反应.
- 拉普加剧了瘤缺氧,激活TPZ并产生H2O2用于增强CDT,从而导致显著的治疗改善.
结论:
- 开发的纳米疗法平台有效地将低氧激活化疗与结肠癌的CDT相结合.
- 与单一疗法相比,这种协同方法显著改善了治疗结果.
- 该战略为克服结肠癌中与TME相关的治疗耐药性提供了一个有希望的新方向.
关键词:
配备了 Cu-doped 的 ZIF-8 系统.化学动力学疗法是一种化学动力学疗法.缺氧 缺氧是指缺氧的情况.协同处理是一种协同处理.提拉帕扎米因 (Tirapazamine) 是一种药物.贝塔拉帕是一种β-lapachone.更多相关视频
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
11.4K
08:03Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
9.5K
相关概念视频
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K